Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.600
-0.140 (-8.05%)
At close: Dec 20, 2024, 4:00 PM
1.550
-0.050 (-3.13%)
After-hours: Dec 20, 2024, 7:01 PM EST

Mersana Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for MRSN stock have an average target of 6.00, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 275.00% from the current stock price of 1.60.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $6.00 $7.00 $9.00
Change +87.50% +275.00% +337.50% +462.50%
* Price targets were last updated on Aug 27, 2024.

Analyst Ratings

The average analyst rating for MRSN stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 333333
Buy 111111
Hold 322222
Sell 000000
Strong Sell 000000
Total 766666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Maintains
$6$5
Strong Buy Maintains $6$5 +212.50% Aug 27, 2024
Baird
Baird
Hold
Maintains
$4$3
Hold Maintains $4$3 +87.50% Aug 14, 2024
JP Morgan
JP Morgan
Hold
Upgrades
$5
Hold Upgrades $5 +212.50% Mar 19, 2024
Wedbush
Wedbush
Buy
Upgrades
$2$7
Buy Upgrades $2$7 +337.50% Feb 29, 2024
Truist Securities
Truist Securities
Strong Buy
Upgrades
$9
Strong Buy Upgrades $9 +462.50% Feb 29, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
32.38M
from 36.86M
Decreased by -12.14%
Revenue Next Year
27.76M
from 32.38M
Decreased by -14.29%
EPS This Year
-0.61
from -1.48
EPS Next Year
-0.56
from -0.61
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
42.12M828.00K43.00K26.58M36.86M32.38M27.76M50.75M
Revenue Growth
297.61%-98.03%-94.81%61,716.28%38.65%-12.14%-14.29%82.86%
EPS
-0.65-1.43-2.41-2.18-1.48-0.61-0.56-0.72
EPS Growth
--------
Forward PE
--------
No. Analysts -----111110
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 38.6M 52.5M 210.0M
Avg 32.4M 27.8M 50.8M
Low 24.6M n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High
4.6%
62.1%
656.6%
Avg
-12.1%
-14.3%
82.9%
Low
-33.2%
- -

EPS Forecast

EPS 202420252026202720282029
High -0.56 -0.22 -0.48
Avg -0.61 -0.56 -0.72
Low -0.65 -0.78 -0.93

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.